Identification of prognostic values defined by copy number variation, mRNA and protein expression of LANCL2 and EGFR in glioblastoma patients

Table 4 Multivariate analysis by the Cox proportional hazard regression model for OS in younger GBM patients (age < 60 yrs) of TCGA database

Variable	HR (95% CI)	P
Gender
Male vs female	2.029 (1.286–3.201)	0.002
LANCL2 gene status
Amplification vs no alteration	1.657 (1.017–2.699)	0.043
EGFR gene status
Amplification vs no alteration	NA	0.624
LANCL2 and EGFR gene status
Co-amplification vs no alteration	NA	NA

ISSN: 1479-5876